SPESOLIMAB
UNII 5IB2J79MCX

Substance Identification & Data

This profile provides standardized clinical and technical data for Spesolimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 5IB2J79MCX.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2097104-58-8 and the RxNorm Concept ID (RxCUI) 2610417. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

5IB2J79MCX

CAS Registry Number

2097104-58-8

RxNorm Concept ID

2610417

Detailed Substance Profile

Preferred Name

SPESOLIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

5IB2J79MCX

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C166849

National Cancer Institute reference terminology for clinical and research data.

INN ID

10845

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

JK-145

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Spesolimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

SPESOLIMAB

SPESOLIMAB-SBZO

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 36 RECEPTOR) (HUMANIZED MONOCLONAL BI 655130 .GAMMA.1-CHAIN), DISULFIDE WITH HUMANIZED MONOCLONAL BI 655130 .KAPPA.-CHAIN, DIMER

SPESOLIMAB [INN]

SPESOLIMAB [JAN]

SPESOLIMAB [USAN]

SPESOLIMAB [WHO-DD]

SPESOLIMAB SBZO [WHO-DD]